Abacavir Sulfate
3 NDCs across 3 manufacturers|2 Generic,1 Brand
Abacavir Sulfate is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 17, 1998, and the first generic was approved Jun 18, 2012. FDA's Orange Book lists 5 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $3 million on Abacavir Sulfate across 16,000 claims for 2,351 beneficiaries.
Abacavir Sulfate is available as 3 NDCs from 3 manufacturers (2 generic, 1 brand), with NADAC prices from $0.55 to $0.55 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
2G / 1B
Manufacturers
3
competing in market
Price Spread
$0.55 – $0.55
per EA, 2 of 3 NDCs
7d Activity
avg +1.4% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
ViiV Healthcare Company manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing ABACAVIR SULFATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ZIAGEN 20 MG/ML SOLUTION | $0.5865 per ML | — |
ABACAVIR 300 MG TABLET | $0.5455 per EA | +1.40% |
ABACAVIR 300 MG TABLET | $0.5455 per EA | +1.40% |
Frequently Asked Questions
What is Abacavir Sulfate used to treat?
Abacavir Sulfate is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.
When did Abacavir Sulfate become available as a generic?
FDA approved the first generic Abacavir Sulfate (ANDA) on Jun 18, 2012. The Orange Book currently lists 5 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Abacavir Sulfate?
In 2024, Medicare Part D spent $3 million on Abacavir Sulfate across 16,000 claims for 2,351 beneficiaries.
How many Abacavir Sulfate products are on the market?
The Abacavir Sulfate drug market contains 3 NDCs from 3 manufacturers — 2 generic and 1 brand product.
What is the price range for Abacavir Sulfate?
NADAC reference prices for Abacavir Sulfate range from $0.5455 to $0.5455 per EA. 1 additional product is priced per a different unit (e.g. liquids per ML) and isn't directly comparable.
Which manufacturers make Abacavir Sulfate?
3 manufacturers list Abacavir Sulfate in NADAC. Ranked by number of NDCs, the largest are ViiV Healthcare Company (1), Mylan Pharmaceuticals Inc. (1), Mylan Institutional LLC (1).
How has the price of Abacavir Sulfate changed recently?
Over the past 7 days, 2 Abacavir Sulfate NDCs rose and 0 fell, with a market-wide average change of +1.4%.